Against a backdrop of growing demand for pharmaceutical products, Oriola-KD anticipates a gain of approximately EUR 60 million in the second quarter of 2010 from the upcoming sale, reinforcing the company's strategic shift towards focusing on pharmaceutical wholesale and retail operations, reflecting confidence in the future growth prospects of the sector.